IWA
MRNA icon

Intercontinental Wealth Advisors’s Moderna MRNA Stock Holding History

Intercontinental Wealth Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,436
Closed -$258K – 311
2022
Q4 		$258K Sell
1,436
-24,891
-95% -$4.07M 0.08% 245
2022
Q3 		$3.11M Buy
26,327
+14,154
+116% +$2.15M 0.98% 12
2022
Q2 		$1.74M Buy
12,173
+1,273
+12% +$182K 0.47% 34
2022
Q1 		$1.88M Buy
+10,900
New +$1.84M 0.43% 38

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Intercontinental Wealth Advisors's MRNA Position: Q1 2023 in Review

Intercontinental Wealth Advisors sold out of Moderna (MRNA) in Q1 2023, closing a stake of 1,436 shares — an estimated $258K sold.

Intercontinental Wealth Advisors first reported a position in MRNA in Q1 2022 and held it in 4 quarters. The position peaked at $3.11M in Q3 2022. 1,017 funds tracked by Wall St. Rank hold MRNA as of Q1 2023.

  • Intercontinental Wealth Advisors reported no remaining Moderna position as of Q1 2023 after selling out during the quarter.
  • Intercontinental Wealth Advisors sold 1,436 Moderna shares in Q1 2023, an estimated $258K.
  • Intercontinental Wealth Advisors first reported a position in Moderna in Q1 2022 and held it in 4 quarters.
  • Intercontinental Wealth Advisors's Moderna position peaked at $3.11M in Q3 2022.
  • 1,017 funds tracked by Wall St. Rank held Moderna as of Q1 2023.

Based on Intercontinental Wealth Advisors's 13F filing for Q1 2023, filed 4 May 2023.